Literature DB >> 6756130

Uremic encephalopathies: clinical, biochemical, and experimental features.

C A Mahoney, A I Arieff.   

Abstract

Patients with renal failure may manifest a variety of neurologic disorders. Patients with chronic renal failure who have not yet received dialytic therapy may develop a symptom complex progressing from mild sensorial clouding to delirium and coma, with tremor, asterixis, multifocal myoclonus, and seizures. After the institution of adequate maintenance dialysis therapy, patients may continue to be afflicted with more subtle nervous dysfunction, including impaired mentation, generalized weakness, and peripheral neuropathy. These central nervous system disorders are referred to as uremic encephalopathy. The dialytic treatment of end-stage renal disease has itself been associated with the emergence of two distinct, new disorders of the central nervous system; dialysis dysequilibrium and dialysis dementia. The dialysis disequilibrium syndrome consists of headache, nausea, muscle cramps, obtundation, and seizures, and is a consequence of the initiation of dialysis therapy in some patients. Dialysis dementia is a progressive, generally fatal encephalopathy which affects patients on chronic hemodialysis. There are at least three different forms of dialysis encephalopathy: sporadic, epidemic; and that associated with renal disease in children. In addition to the foregoing neurologic diseases which are specifically related to uremia and/or dialysis, a number of other neurologic disorders occur with increased frequency in patients with end-stage renal disease on chronic hemodialysis. These include subdural hematoma, electrolyte disorders, vitamin deficiencies, drug intoxication, hypertensive encephalopathy, and acute trace element intoxication. Renal transplantation is associated with a variety of central nervous system infections, reticulum cell sarcoma, and central pontine myelinosis. The present manuscript will review the clinical, structural, and biochemical components of those neurologic disorders which are peculiar to the uremic state and its treatment with dialysis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6756130     DOI: 10.1016/s0272-6386(82)80090-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  14 in total

1.  The syndrome of delayed post-hypoxic leukoencephalopathy.

Authors:  David Shprecher; Lahar Mehta
Journal:  NeuroRehabilitation       Date:  2010       Impact factor: 2.138

2.  Hemodialysis increases apparent diffusion coefficient of brain water in nephrectomized rats measured by isotropic diffusion-weighted magnetic resonance imaging.

Authors:  J P Galons; T Trouard; A F Gmitro; Y H Lien
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Metabolic Encephalopathy: Behind the Name.

Authors:  Eelco F M Wijdicks
Journal:  Neurocrit Care       Date:  2018-12       Impact factor: 3.210

4.  A preliminary report of brain edema in patients with uremia at first hemodialysis: evaluation by diffusion-weighted MR imaging.

Authors:  C L Chen; P H Lai; K J Chou; P T Lee; H M Chung; H C Fang
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

5.  Dialysis disequilibrium syndrome.

Authors:  C P Harris; J J Townsend
Journal:  West J Med       Date:  1989-07

6.  Brain urea increase is an early Huntington's disease pathogenic event observed in a prodromal transgenic sheep model and HD cases.

Authors:  Renee R Handley; Suzanne J Reid; Rudiger Brauning; Paul Maclean; Emily R Mears; Imche Fourie; Stefano Patassini; Garth J S Cooper; Skye R Rudiger; Clive J McLaughlan; Paul J Verma; James F Gusella; Marcy E MacDonald; Henry J Waldvogel; C Simon Bawden; Richard L M Faull; Russell G Snell
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-11       Impact factor: 11.205

Review 7.  Dialysis disequilibrium syndrome.

Authors:  Diana Zepeda-Orozco; Raymond Quigley
Journal:  Pediatr Nephrol       Date:  2012-06-19       Impact factor: 3.714

8.  Evaluation of brain and kidney energy metabolism in an animal model of contrast-induced nephropathy.

Authors:  Clarissa A Roza; Giselli Scaini; Isabela C Jeremias; Gabriela K Ferreira; Natalia Rochi; Joana Benedet; Gislaine T Rezin; Francieli Vuolo; Larissa S Constantino; Fabricia C Petronilho; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2011-03-25       Impact factor: 3.584

Review 9.  Extracorporeal treatment of acute renal failure in the intensive care unit: a critical view.

Authors:  M Schetz; P M Lauwers; P Ferdinande
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 10.  A review of continuous renal replacement therapy.

Authors:  C G Flynn
Journal:  Ir J Med Sci       Date:  1994-07       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.